Weight Loss Medications: Keeping Safe and Informed
Weight loss is a common goal for many people, and as the demand for quick and easy solutions increases, so does the popularity of weight loss medications. However, the Illinois Poison Center has seen a rise in calls from individuals who have unintentionally misused or misdosed these medications. It is important for individuals to be aware of the potential risks and to take these medications under the guidance of a licensed healthcare professional.
According to Matt Novak, a trained pharmacist and certified specialist in poison information, the Illinois Poison Center received 61 phone calls in 2022. However, in 2023, that number nearly doubled to 121, and with 35 calls in the first quarter of 2024, it is on pace to surpass the previous year. This trend is alarming and serves as a reminder for individuals to be cautious when using weight loss medications.
Dr. Michael Wahl, medical director for the Illinois Poison Center, believes that the rise in calls is due to more people using these medications. He also notes that some individuals may be confused by the injector pens used to administer the medication. In certain cases, people may give themselves up to 10 times the recommended dosage, leading to complications such as nausea, vomiting, diarrhea, and dizziness.
Attorney Tony Simon has filed several lawsuits against Novo Nordisk, the maker of Ozempic, claiming that the drug maker did not adequately warn about potential complications, including stomach paralysis. Simon believes that it is essential for drug manufacturers to provide comprehensive and accurate information about the potential risks, so that patients, together with their healthcare providers, can make informed decisions about their treatment.
In response to the Illinois lawsuits, Novo Nordisk issued a statement stating that they believe the allegations to be without merit and that they will vigorously defend against the claims. They also emphasize that patient safety is their top priority and that they continuously work with the U.S. Food and Drug Administration to monitor the safety of their medicines. Novo Nordisk stands behind the safety and efficacy of all their GLP-1 medicines when used as directed, under the care of a licensed healthcare professional.
However, for Rita Glaze-Rowe, president of Transformative Healthcare Markets for Real Chemistry, a healthcare innovations company, the problem may lie in people’s impatience. She notes that individuals are seeking easier and quicker access to these medications, resulting in shortages of some medications such as Mounjaro, Zepbound, and Wegovy. This high demand has also led to the rise of “GLP-1 influencers,” who promote their experience with weight loss medications on social media and drive people to med spas, telehealth providers, and compounding pharmacies.
The use of compounding pharmacies is a cause for concern, as they offer FDA-approved weight loss medications in compounded forms that may be easier to access and cheaper. However, this can be a dangerous practice as compounded medications are not regulated and may not have the same safety profile as FDA-approved medications. Dr. Naomi Parrella, chief of lifestyle medicine at RUSH University Medical Center, cautions against purchasing these medications from compounding pharmacies, stating that the FDA has been clear about its stance on this issue. It is crucial to obtain proper information and guidance from a healthcare professional before starting any weight loss medication.
Moreover, Matt Novak, who has fielded calls at the Illinois Poison Center, has seen cases of individuals taking compounded versions of these medications and facing dangerous consequences. He notes that individuals are not properly trained on how to administer these medications, resulting in overdosing. Dr. Parrella echoes this concern and emphasizes the importance of being fully informed and aware of how to take these medications safely.
In conclusion, as weight loss medications continue to grow in popularity, it is imperative for individuals to be well-informed and aware of the potential risks. These medications should only be taken under the guidance of a licensed healthcare professional, and individuals should be cautious of unregulated sources such as compounding pharmacies. The key is to prioritize safety and make informed decisions about one’s health and well-being. Let’s work together to achieve our weight loss goals in a safe and healthy manner.
